Cargando…
Activation of PPARγ in Myeloid Cells Promotes Lung Cancer Progression and Metastasis
Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits growth of cancer cells including non-small cell lung cancer (NSCLC). Clinically, use of thiazolidinediones, which are pharmacological activators of PPARγ is associated with a lower risk of developing lung cancer. However, th...
Autores principales: | Li, Howard, Sorenson, Amber L., Poczobutt, Joanna, Amin, Jay, Joyal, Teresa, Sullivan, Timothy, Crossno, Joseph T., Weiser-Evans, Mary C. M., Nemenoff, Raphael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228753/ https://www.ncbi.nlm.nih.gov/pubmed/22145026 http://dx.doi.org/10.1371/journal.pone.0028133 |
Ejemplares similares
-
Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis
por: Nemenoff, Raphael
Publicado: (2012) -
Anti- and Protumorigenic Effects of PPARγ in Lung Cancer Progression: A Double-Edged Sword
por: Li, Howard, et al.
Publicado: (2012) -
Eicosanoid Profiling in an Orthotopic Model of Lung Cancer Progression by Mass Spectrometry Demonstrates Selective Production of Leukotrienes by Inflammatory Cells of the Microenvironment
por: Poczobutt, Joanna M., et al.
Publicado: (2013) -
Activation and Molecular Targets of Peroxisome Proliferator-Activated Receptor-γ Ligands in Lung Cancer
por: Nemenoff, Raphael A., et al.
Publicado: (2008) -
Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti–PD-1 response in NSCLC
por: Bullock, Bonnie L, et al.
Publicado: (2019)